Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-15T08:28:59.906Z Has data issue: false hasContentIssue false
  • English
  • Français

Adjuvant Radiotherapy in Breast Cancer: Consideration of Cost-Benefits in Relation to the CRC (King's/Cambridge) Trial

Published online by Cambridge University Press:  10 March 2009

Joan Houghton  and
Michael Baum
Joan Houghton
Affiliation:
King's College School of Medicine and Dentistry, Rayne Institute
Michael Baum
Affiliation:
King's College School of Medicine and Dentistry, Rayne Institute
Get access Rights & Permissions [Opens in a new window]

Extract

The Cancer Research Campaign (CRC) Trial demonstrates a decreased incidence of local recurrence for patients randomized to prophylactic radiotherapy following mastectomy. Irradiated patients alive after 5 years, however, have a small increased risk of dying from causes other than breast cancer. How to estimate the cost-benefit of such therapy is discussed.

Type
Special Section: Technology Assessment and Surgical Policy
Information
International Journal of Technology Assessment in Health Care , Volume 5 , Issue 3 , July 1989 , pp. 415 - 422
Copyright
Copyright © Cambridge University Press 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Brinkley, D., Haybittle, J. L., & Houghton, J., The Cancer Research Campaign (King's/Cambridge) Trial for early breast cancer: An analysis of the radiotherapy data. British Journal of Radiology, 1984, 57, 309–16.CrossRefGoogle ScholarPubMed
Cancer Research Campaign Working Party. Cancer Research Campaign (King's/Cambridge) Trial for early breast cancer. Lancel, 1980, 2, 55–60.Google Scholar
Elston, C. W., Gresham, G. A., Rao, G. S. et al. The Cancer Research Campaign (King's/ Cambridge) trial for early breast cancer: Clinico-pathological aspects. British Journal of Cancer, 1982, 45, 655–69.CrossRefGoogle ScholarPubMed
Gelber, R. D., & Goldhirsch, A.A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. Journal of Clinical Oncology, 1986, 4, 1772–79.CrossRefGoogle ScholarPubMed
Williams, A.Economics of coronary artery bypass. British Medical Journal, 1985, 291, 326–29.Google ScholarPubMed